Onconova Therapeutics Inc (ONTX)
Delisted
5 Aug 2026
NASDAQ (CM) NASDAQ (CM) Primary $
16. 59
-1.45
-8.0377%
$
669.3K Market Cap
- P/E Ratio
- Div Yield
34,083 Volume
-0.96 Eps
$ 18.04
Previous Close Investors:
Day Range
16.52 18.3
Year Range
10.62 43.14
Want to track ONTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Onconova Therapeutics Inc (ONTX) Statistics
Valuation metrics
Market Cap 669.3K
Enterprise value -2.06M
Trailing P/E (ttm) -0.07
Forward P/E -1.16
PEG ratio 0
Price/Sales (ttm) 0
Price/Book (mrq) -43.19
Enterprise Value/Revenue -0
Enterprise Value/EBITDA -0.03
Overview
Shares outstanding 21M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.41K
Average volume (90 days) 2.33M
Price summary
52-Week low 10.62
52-Week high 43.14
Beta -
50-Day moving average 12.86
200-Day moving average 4.43
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 21 May 2021
Financials
Fiscal year
Fiscal year ends 31 Dec 2023
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin -0.01%
Operating margin -2.94%
Operational effectiveness
Return on assets -1.99%
Return on equity -0.01%
Income Statement
Revenue (ttm) 226K
Revenue per share (ttm) 262.2
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -18.95M
Diluted EPS (ttm) -1.53
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.29
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.43%
Book value per share (mrq) -0.5
Cash Flow
Cash flow statement -16.09M
Levered free cash flow (LFCF) -18.95M
